Neuralli Mood: Two acid-resistant capsules taken once daily for 90 days. Each daily dose contains 30 billion CFU of L. plantarum PS128 and 20 billion heat-treated cells of L. paracasei PS23. Other ingredients include microcrystalline cellulose, hypromellose, pectin, glycerol, silica, and magnesium stearate.
Study summary
This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Age 18 years or older and able to provide informed consent.
* Generally healthy adult experiencing stress, occasional sleep disruption, low mood, anxiety symptoms, or work-related burnout.
* Willing and able to take two capsules of Neuralli Mood daily for 90 days.
* Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments.
* Has reliable access to the internet and an email-enabled device.
Exclusion Criteria:
* Pregnant or nursing.
* Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient.
* Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate.
* Immunocompromised status or current immunosuppressive therapy.
* Severe or unstable mood disorder, acute psychiatric symptoms, or a current risk of harm to self or others.
* A clinically significant sleep disorder for which participation or changes in symptoms should be managed by a healthcare professional.
* Cognitive impairment or another condition that prevents informed consent or reliable completion of study procedures.
* History of a severe allergic reaction when the investigator determines probiotic use may present an unacceptable risk.
* Use of a medication or presence of a medical condition for which a healthcare professional advises against probiotic supplementation.
* Any other circumstance that, in the investigator's judgment, makes participation inappropriate or unsafe.
Primary outcome measure(s)
Change in Depression Anxiety and Stress Scales-21 Stress Subscale Score — Baseline before the first dose and end of the 90-day supplementation period Change from baseline in the Stress subscale score of the Depression Anxiety and Stress Scales-21. Higher scores (maximum score of 42) represent greater severity of stress symptoms. (Minimum score of 0).
Change in PROMIS Sleep Disturbance Score — Baseline before the first dose and end of the 90-day supplementation period Change from baseline in the PROMIS Sleep Disturbance score. Higher scores (Maximum 40) represent greater sleep disturbance. Lower (Minimum 8) represent lower sleep disturbance.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.